Inflammatory bowel disease (IBD) is a group of chronic multifactorial disorders. According to a recent study, the number of IBD association loci is increased to 201, of which 37 and 27 loci contribute specifically to the development of Crohn's disease and ulcerative colitis respectively. Some IBD associated genes are involved in innate immunity, in the autophagy and in the inflammatory response such as NOD2 , ATG16L1 and IL23R , while other are implicated in immune mediated disease (STAT3 ) and in susceptibility to mycobacterium infection (IL12B ). In case of early onset of IBD (VEO-IBD) within the 6 th year of age, the disease may be caused by mutations in genes responsible for severe monogenic disorders such as the primary immunodeficiency diseases. In this review we discuss how these monogenic disorders through different immune mechanisms can similarly be responsible of VEO-IBD phenotype. Moreover we would highlight how the identification of pathogenic genes by Next Generation Sequencing technologies can allow to obtain a rapid diagnosis and to apply specific therapies.
INTRODUCTION
Inflammatory bowel disease (IBD) is the result of an unbalanced crosstalk between gut luminal content and the mucosal immune system. IBD encompasses a continuum of clinical disorders, ranging from Crohn' s disease (CD) through indeterminate colitis (IC) to ulcerative colitis (UC). In fact, some patients may present significant clinical overlap between these forms and even develop one form from another. However, there are distinctive genetic, environmental and pathogenic factors that can be involved in the three forms.
In general, CD is characterized by changes in intestinal microbiota (dysbiosis), focal translocation of bacteria across the mucosal barrier, altered mucosal response to bacterial invasion, development of chronic granulomatous inflammation and activation of adaptive immunity as results of compensatory mechanisms to minor defects of innate immunity or autophagy. Genetic factors can involve variants of different groups of genes, leading to a leaky epithelial barrier and impaired mechanisms of phagocytosis and autophagy. Whatever is the particular combination of factors in each patient, the common result is a vicious circle of dysbiosis, granulomatous inflammation and activation of T cell immunity [1] . In contrast, a major role in UC seems to be played by dysregulation of lymphocyte immunity, with increased activation of T cells and/or reduced regulatory T cell function. Risk factors implicate a number of variants in genes associated with T cell activity and with down regulation of mucosal inflam mation.
Furthermore, intermediate forms of IBD can share various clinical and genetic features with both CD and UC [2, 3] . Indeterminate colitis is particularly common among subjects with very early onset in the first years of life (VEOIBD). Indeed, patients with VEOIBD present quite distinctive clinical features and display worse clinical course and usually poorer response to treatments compared with adult onset disease.
Although genetic factors have been associated with different forms of IBD, the diagnosis in each subject is commonly based on clinical and histopathology data, rather than genetic results. Indeed, the particular profile of common genetic variants has little con sequences on the prediction of the disease course and response to treatments.
However, genetic analysis can have an important impact on clinical practice for VEOIBD.
Monogenic disorders are believed to be very rare, but it is expected that in the severe form of earlier onset of IBD, genetic factors play a significant role in pathogenesis. In some cases, VEOIBD can result from monogenic disorders such as primary immuno deficiency diseases (PID).
Several anecdotal reports showed that a number of PIDs can onset with a clinical presentation compatible with IBD. Taking into account this possibility can allow genetic confirmation and effective treatment with hematopoietic stem cell transplantation (HSCT), avoiding ineffective and dangerous treatments with immunosuppressant, biological inhibitors and even surgery. In most cases, the application of an integrated clinical, functional and genetic approach can allow the identification of some PID diagnosis, however clinical and functional signs can be unexpressed or overlooked and the correct genetic assay may be delayed. Thus, given the importance of the earliest detection of PID, we dedicated in this review a large space to the detailed description of monogenic forms of IBD. We also highlight the potential role of severe VEOIBD.
In the first part of this review, we will discuss about the susceptibility to develop IBD followed by how the availability of improved genetic tools can impact on the early diagnostics of monogenic VEOIBD.
In addition, the study of monogenic causes of IBD may provide significant information for a better understanding of sporadic adult onset disease. Indeed, the role of defective mucosal immunity in IBD is a fundamental unsolved question.
Increasing evidence support the idea that in most cases hyperactive intestinal inflammation can be the result of compensatory responses to the environment in presence of various immune defects. The study of genetic variants in monogenic and in sporadic IBD could help unraveling the complex interplay between defective and compensatory immune responses, opening the way to the identification of new targets for therapy.
In the second part of this review, we will discuss how defects in regulation of innate or adaptive immunity can be relevant to the pathogenesis of inflammation in IBD.
GENES INVOLVED IN MULTIFACTORIAL

SUSCEPTIBILITY IBD
Until the last year several genomewide associations studies (GWAS), followed by meta analysis of both principal forms of IBD (CD and UC) identified a total of 163 IBD loci: 60 loci with heterogeneous effects while the effects of the other 50 loci were not distinguishable in CD or UC. The remaining 53 loci were specific only for CD (n = 30) or for UC (n = 23). A total of 113 of the 163 IBD loci were shared with other complex traits such as immune mediated diseases and mycobacterial infection [46] . Recently by immunochip genotype data from both European and East Asian, Indian or Iranian cohorts implicate new 38 loci in IBD risk most of which (27 loci) contribute to both diseases (CD and UC) while of the remaining 11 loci, 7 were classified as specific to CD and 4 to UC [7] . The innate immune receptor nucleotide oligo merization domain containing 2 (NOD2) was the first gene associated with inflammatory bowel disease [8, 9] . Three mutations (R702W, R703C and L1007fs) in the NOD2 coding region were demonstrated to be asso ciated with CD in Quebec affected patients that carried at least one variant [10] .
In Hungarian CD patients, as well as in other countries, the threementioned NOD2 variant are associated with early onset and the presence of one variant allele increases the risk for developing CD from 1.5 to 4.3 folds, while two variants alleles increase susceptibility to develop the disease from 20 to 40 folds compared with the general population [11] . The mechanisms linking NOD2 variants to the risk of CD are not fully clear. In fact, these variants lead to lossoffunction of the protein, suggesting a link between an impaired innate immune response to bacterial infections and disease development [8, 9] . In contrast, NOD2 gainoffunction mutations, in the NATCH domain of the receptor, are associated with Blau Syndrome (BS) and early onset Sarcoidosis (EOS), causing a rare autosomal dominant disease characterized by a triad of symptoms (rashes, uveitis and arthritis) and onset among 3 and 4 years of age [12, 13] .
Another strong association with CD regards the autophagy related 16like 1 (ATG16L1) gene [14, 15] , while interlukin23 receptor (IL23R) gene, results associated with both UC and CD [16] . Few GWAS have been performed also in pediatric patients: a study identified for the first time for pediatric IBD onset the TNFRSF6B gene within the 20q13 and the PSMG1 gene within the 21q22 loci [17] . In early onset cases, an association was described between IL23R, STAT3, JAK2 and IL12B and CD [18, 19] . Most of these genes concern the functions of innate immunity, autophagy and inflammatory cytokines production. In addition, the associations with HNF4A and GNA12 point out the role of defects of epithelial barrier function [20] . Moreover Kaser et al [21] identified an association among hypomorphic XBP1 variants with both IBD forms, reporting that the deletion in the intestinal epithelial cells induces spontaneous enteritis.
A study carried out on the Korean population proves the different genetics IBD among different populations. Several Korean children suffered from UC at the time of diagnosis showed diarrhea and hematochezia like the features in Western studies. In a particular way this study demonstrated that genetic of the IBD between the affected populations reflects the ethnic differences. In fact the NOD2 and ATG16L1 variants, strongly associated with IBD in western populations, were not associated in the Korean IBD patients, who conversely displayed an association with three genes (ATG16L2, DUSP5 and TBC1D1) that aren't associated in Western population [22] . Recently, new technologies allow expanding the possibility of genetic analysis in IBD. Indeed, Whole Exome Sequencing studies (WES) performed the identification of further genetic association with CD, including missense mutations in the PR domain containing 1 (PRDM1), that encodes a transcription factor expressed by T and B cells, and a common variation in Nuclear domain 10 protein 52 (NDP52), an adaptor protein that acts in selective autophagy of intracellular bacteria [23] . In addition, Xu et al [24] discovered in Chinese patients by WES novel genetic variants in the DLG1 gene involved in cell proliferation, T cell polarity and T cell receptor signalling, as a susceptibility gene for CD.
MONOGENIC FORMS IN EARLY ONSET IBD
EOIBD is defined by the onset of disease within the 6 th year of age. This group includes neonatal IBD (first 28 d of age), Infant and toddler onset IBD (younger than 2 years, VEOIBD), and early childhood groups [25] . In VEOIBD, the disease tend to be much more severe and much more difficult to control with conventional therapies, compared with adultonset IBD. Increasing evidence suggest a stronger genetic contribution to these forms compared with adults. Indeed some patients with VEOIBD may have developed intestinal inflammation as part of a monogenic disease, usually a PID. In fact, these cases may account, at least in part, for the phenomenon of missing heritability in IBD, which is the inability to explain all the genetic contribution to IBD based solely on the additive effect of common risk gene variants [26] . Overall, at least 58 genes can play a role in VEOIBD (Table 1 ), in addition to those associated with susceptibility to multifactorial IBD. Most of these genes are the cause of very rare monogenic disorders that can present with clinical and histopathological features similar to IBD. The different diseases associated with early onset IBDlike symptoms have been recently reviewed elsewhere [27] . Distinguishing monogenic forms among VEOIBD is a crucial importance to allow the best treatment. A panel of candidate genes used for the analysis of VEOIBD can allow a timing diagnosis and an effective cure in many patients, as well as an epidemiologic definition of the real impact of PIDs in this field.
However, it is worth noting that most cases of VEOIBD can still recognize a multifactorial origin, as suggested by the evidence of the increased incidence of early onset cases of IBD in recent decades, reaching 4.37 per 100000 children [25] . Below we discuss how monogenic disorders involving different immune mechanisms can similarly be responsible for VEOIBD.
Hyper and autoinflammatory disorders
A chronic or episodic inflammatory disease of the intestine can occur as part of a complex clinical picture in subjects affected by several autoinflammatory disorders.
Mevalonate kinase deficiency (MKD) is an auto somal recessive disease caused by mutations in the MVK gene and it is characterized by febrile attacks associated with diarrhea, vomiting and abdominal pain. The occurrence of abdominal pain and diarrhea, sometimes with blood and mucus, together with leukocytosis, chronic anemia and increased CRP could raise the suspicion of IBD [28] . In most cases intestinal inflammation occurs only during febrile flares, yet the use of glucocorticoids can hidden the typical periodicity of the disease, reducing the severity but increasing the frequency of symptoms, thus making more difficult the diagnosis [29] . In some cases, patients with MKD may present with VEOIBD with the characteristics of indeterminate colitis. Of note, treatment with antiIL1 agents can allow relieving inflammatory colitis as well as other febrile and inflammatory features typical of the disease [3032] . IBD can be also more frequent and severe in patients with MEFV mutations. Identification of MEFV can allow diagnosis of Familial Mediterranean Fever and effective treatment with colchicine [33, 34] . Recently, a de novo missense mutation (S707T) in the PLCG2 gene has been detected by the exome analysis in two patients suffering from an autosomal dominant inflammatory disorder with severe enterocolitis and mild immunodeficiency, even if it is not clear whether gut inflammation is facilitated by the hyper inflammatory defect or by the immunodeficiency [35] . Familial cold autoinflammatory syndrome2, a systemic autoinflammatory disease caused by hetero zygous mutations in the NLRP12 gene can present abdominal pain vomiting and buccal aphthous ulcers together with coldinduced fever [36] and in some cases hypogammaglobulinemia [37] . Familial cold autoinflammatory syndrome 4 is an autosomal dominant disease caused by heterozygous mutation in the NLRC4 gene and characterized by intermittent episodes of rash, arthralgia, and fever after exposure to cold [38] . Recently a family was reported with a syndrome featuring neonatal onset enterocolitis, in which the father and two respective sons carried a missense mutation (V341A) in the NLRC4 gene. It has also been shown that this mutation, functionally associated with gain of function, cosegregates in the family with the disease [39] . Canna et al [40] report a de novo missense sub stitution (T337S) on NLRC4 NBD domain that causes early onset recurrent fever flares and macrophage activation syndrome (MAS).
Defect of cytotoxicity and hyperinflammation
The association of inflammatory enterocolitis with MAS can be found also in subjects with XIAP mutations, as described by Worthey [41] . Indeed, XIAP deficiency, already associated with Xlinked lymphoproliferative syndrome2 (XLP2), can be the cause of Crohn's like features in the absence of MAS [42] . In particular, Zeissig et al [43] identified XIAP private variants in absence of symptoms related to XLP2 in a cohort of German boys with early onset CD. Of note, macrophage activation in subjects with XIAP deficiency is a compensatory phenomenon sustained by Interferonγ production by lymphocytes and natural killer cells with impaired antiviral capacity, thus it is not of autoinflammatory origin. Similarly, the development of Crohn'slike disease seem to be due to a deficiency rather than to an excess of XIAP function, leading to defective activation of NOD2 in monocytes. In contrast to lymphohistiocytosis, IBD has been reported also in female subjects heterozygous for XIAP mutations [44] . Inflammatory colitis has been reported also in anecdotal cases of subjects with Xlinked lympho proliferative syndrome, although in this case the mechanisms are unknown [45] . HermanskyPudlak syndrome (HPS) is a rare autosomal recessive disease characterized by typical syndromic features including albinism, hemorrhagic diathesis, and pigmented reticuloendothelial cells. The HPS patients with specific mutations in the respective genes (HPS-1, HPS-4 , HPS-6) have major organ involvement including also severe granulomatous colitis with pathologic features suggestive of CD [4650] .
Immune regulation and dysregulation disorders (innate and adaptive immune responses)
Autoimmune enteropathy is part of the Xlinked immune dysregulation, polyendocrinopathy, entero pathy disease and it is caused by FOXP3 gene mutations. Although the disorder has distinctive features making it well distinguishable from IBD, mutation in FOXP3 have been recently associated with veryearly IBD phenotype [51] . Autoimmune enteropathy has been described, albeit more rarely, also in the autoimmune polyen docrinopathy syndrome type [52] . In recent years, several studies highlighted the causative role of the immunoregulatory cytokine IL-10 and of its receptor in the early onset IBD [5362] and the genetic analysis of IL-10, IL10RA, IL10RB has became routinely in patients who developed the first symptoms within the 3 mo of life, regardless of parents' consanguinity [63] .
Defects in phagocyte bacterial killing and neutropenia
Neutrophil defects are often associated with intestinal inflammation. In particular, subjects with glycogen storage diseasetype 1b show neutrophil dysfunction and run increased risk of developing Crohn's Disease like [6466] . In a similar manner, subjects with defect of G6PC3, often develop CDlike inflammation, which is also associated with persistent T cell lymphopenia [67] .
Other neutrophil defects associate with early onset IBD include Leukocyte Adhesion Deficiency1 (LAD1, ITGB2 mutated), which can be associated with chronic ileocolitis [68] , early onset ulcerative colitis and a non specific Crohn's like colitis [69] as well as with bacterial infections. However, the best characterized defect of pha gocytes associated with VEOIBD is chronic gra nulomatous disease (CGD), both in its Xlinked and autosomal recessive forms. Severe infections by catalase positive bacteria and fungi are usually prominent clinical features, however, cases presenting first with intestinal inflammation, often in the first months of life, are not rare, in particular among subjects with autosomal recessive CGD [7073] . IBD in subjects with CGD reproduces the clinicopathological features of CD [74] . Recently, Dhillon et al [75] found some variants in heterozygosis in NADPH complex genes not leading to appreciable immunodeficiency, yet associated with susceptibility to VEOIBD. Actually, the pathogenesis of inflammation in CGD could also be attributed to a deficiency of autophagy, leading to autoinflammatory response dominated by IL1 release [76] .
T and B lymphocyte selection and activation defects
Intestinal inflammation is a common feature in several PID affecting adaptive immunity. Wiskott Aldrich Syndrome, an Xlinked PID due to mutation in WASP protein, can often present with neonatal or infantile hemorrhagic and inflammatory colitis that can occur before other typical signs such as dermatitis and infections [77, 78] . Thrombocytopenia with small platelets and in some cases also hypogam maglobulinemia usually with normal/highIgA can help addressing the correct diagnosis [79] . Severe combined immunodeficiency (SCID) is often followed by enteropathy and failure to thrive, even before infections. In some cases a low lymphocyte count per age can raise the suspicion of SCID. However, in other cases with hypomorphic mutations in SCID associated genes, such as DCLRE1C, RAG1, RAG2, LIG4, ADA, IL2RG, CD3G, ZAP70 and LCK, lymphocyte count can be normal due to the develo pment of dysfunctional lymphocytes [25, 8084] . Rarely, a leaky SCID may present for years with IBD only, in the absence of severe infections. The presence of other signs such as severe eczematous rash should raise the suspicion of a SCID [81, 85] . In all these cases only the analysis of lymphocyte subsets, and in particular of recent thymic emigrants (or the molecular measure of T cell receptor excision circles) can assist the correct diagnosis [86] . Common variable immunodeficiency (CVID) is also associated with intestinal inflammation, but the disease rarely occurs in the first years of life [87, 88] . The development of IBD seems to be favorished by dysregulation of Tcells derived cytokines [89] .
Although the CVID is a polygenic disease, there are a low percentage of cases due to specific genetic defects such as LPSresponsive beigelike anchor (LRBA), ICOS and IL-21, which may often present with earlier onset in life.
In particular, deficiency of the LRBA gene has been found in patients affected by CVID with early onset hypogammaglobulinemia, inflammatory bowel disease and autoimmune cytopenia [88, 90] . Serwas et al [91] re cently identified a new missense mutation in the LRBA gene in a young girl with severe early IBDlike disease without other manifestations of immunodeficiency.
Other forms of CVID associated with IBD include deficiencies of ICOS gene, CTLA-4, PD-1, IL-21, TNFRSF13B and COG6 [9295] .
IBDlike phenotype was observed also in patients with hyperIgM syndrome resulting from defects in the CD40 ligand [96, 97] , AID genes [98] and in subjects with agammaglobulinemia due to defects in BTK [99, 100] or PIK3R1 [101] .
Disorders of apoptosis
Several cellular mechanisms such as the embryonic development, cell differentiation and the elimination from the intestine and from other body parts are regulated by the caspases that are cysteine proteases. Caspase dysfunction has been associated with IBD, in particular CASP8 is involved in the inflammation of the mucosa and controls in the CD patients the necroptosis of the Paneth cells and the death of the epithelial cells [102] .
Well defined syndromes associated with early onset IBD
The multiple intestinal atresia (MIA) combined with SCID, is caused by mutations in the TTC7A gene [103] . Recently MIA was reported in different families with a very early onset form of apoptotic enterocolitis [104, 105] . Another immunodeficiency associated with low numbers of B cells and immunoglobulins is the Tricho Hepato Enteric Syndrome, a syndromic diarrhea usually associated with mutations in the TTC37 or in the SKIV2L gene [106108] . Xlinked anhidrotic ectodermal dysplasia with immunodeficiency, caused by hypomorphic mutations in the nuclear factorkB essential modulator (NEMO), is associated both with epithelial and immune defects. Except for syndromic features of ectodermal dysplasia and susceptibility to infection from various pathogens, patients often present severe chronic colitis, which in some cases has been reported to worsen after HSCT, probably depending on the engraftment of donor immune cells on the background of defective host epithelial cells [109, 110] .
Other syndromes with early onset chronic diarrhea intestinal inflammation comprise defects of GUCY2C, an intestinal receptor for the heat stable bacterial enterotoxins [111] , ITCH, involved in the ubiquitinediting protein complex [112] , and MASP2 which is an important bactericidal factor [113] .
Defects affecting the integrity of intestinal barrier
Mutations in the type Ⅶ collagen gene (COL7A1) induced the dystrophic epidermolysis bullosa, a geno dermatosis. IBD can develop both from mutations in COL7A1 and from acquired defects in this protein due to autoimmunity [27, 114] . Other molecules involved in the intestinal barrier include ADAM17A, which has been associated to an autosomal neonatal recessive syndrome characterized by inflammatory skin and bowel disease [115] .
Recessive mutations in KIND1/FERMT1 gene are responsible for Kindler syndrome, characterized by skin blistering, poikiloderma, photosensitivity and sometimes UClike gastrointestinal symptoms and haemorrhagic diarrhea [116] . EOIBD can be observed also in patients with EGFR deficiency, together with skin disease [117, 118] . More complex is probably the pathogenesis of IBD in LoeysDietz syndrome, an autosomal disease caused by mutations in the TGFBR1 and TGFBR2 genes that encode respectively for the receptor type 1 and 2 of the transforming growth factor β [119] .
CONCLUSION
When we are faced with a patient with symptoms related to chronic inflammatory bowel disease, it is essential to consider first both the age of onset and the severity of symptoms just to find out whether the patient is suffering from classical multifactorial IBD or if we are facing a severe clinical case, potentially caused by a monogenic form, as which characterized by a more severe phenotype and resistant to tra ditional therapies. This first classification is critical to guide genetic investigation. The identification of monogenic forms, that are quite rare, can have high impact on the therapeutic options, with particular reference to hematopoietic stem cell transplantation. Thus, in case with early onset and severe or atypical features, the genetic research should be directed toward the identification of a mendelian form of the disease. Target sequencing of multiple candidate genes can be accomplished with technologies such as the ION TORRENT, which are now available in many laboratories. The target sequencing must be designed to analyze all those genes that up to that time have been identified associated with a particular phenotype with severe early onset. In cases with high suspicion of a mendelian cause, but with normal target sequencing results, a more complete and sensitive analysis can be performed by comparison of the patients' whole exome sequence with that of their parents and/or relatives [120] . When a monogenic disorder underlying intestinal inflammation is detected, we should discard the diagnosis of IBD and refer to IBDlike inflammation. This is easy and correct when we are dealing with well defined PID, such as Wiskott Aldrich disease or chronic granulomatous disease. The distinction is much more tricky when we found other immune defects, such as those involving XIAP or LRBA.
An easy distinction could be based on the functional consequences of the genetic defect. It has been proposed that cases with lack of immunity should be indicated as PID, whilst the diagnosis of IBD should be reserved to cases with hyperresponse of innate and adaptive immunity. However, it has been argued that excessive or defective immune responses can lead to similar inflammatory disorders, highlighting the importance of a proper functioning of immunity for intestinal homeostasis [121] . What makes even more complicated the clinical picture, is the fact that, a continuum may exist between severe defect, leading to both infections and inflammation signs, and mild defect, presenting only inflammatory signs.
Molecular genetics can help distinguishing inborn defects with excessive or defective immunity but, even more importantly, allow to discriminate defects expressed only in hematopoieticderived cells from defect with an important role also in intestinal epithelium. In the first case (e.g., in subjects with neutropenias, Wiskott Aldrich disease and chronic granulomatous disease) HSCT is able to cure both the immunodeficiency and gut inflammation; in the second case (e.g., defects of NEMO, NOD2) HSCT can be ineffective. More difficult is to predict the success of HSCT in other disorders in which the genetic defect can be important both in hematopoieticderived cells and epithelia.
In brief, inflammatory bowel disease can be the result of different genetic mechanisms leading to common inflammatory phenotypes and requiring similar treatments. VEOIBD is often resistant to con ventional treatment.
Finding the molecular cause in single individuals could open the way to the development of novel and more specific therapeutic approaches.
